NCT06035445

Brief Summary

This is a cluster randomized controlled trial determining the effectiveness of in-person or mHealth-based adolescent-friendly transition interventions compared to standard care on retention in care and viral suppression among adolescents living with HIV who have low transition readiness. Participants are adolescents living with HIV ages 15 to 19 years old in KwaZulu-Natal, South Africa.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
570

participants targeted

Target at P75+ for not_applicable

Timeline
20mo left

Started Feb 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
Feb 2024Dec 2027

First Submitted

Initial submission to the registry

September 6, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 13, 2023

Completed
5 months until next milestone

Study Start

First participant enrolled

February 2, 2024

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

March 9, 2026

Status Verified

March 1, 2026

Enrollment Period

3.9 years

First QC Date

September 6, 2023

Last Update Submit

March 5, 2026

Conditions

Keywords

transition of careadolescent

Outcome Measures

Primary Outcomes (2)

  • Number of Participants Retained in Care

    Clinic patients are considered to be retained in care if 80% of ART pharmacy refills are filled on time (\< 7days from scheduled date) and 80% of scheduled clinic appointments are attended.

    After the 9 month intervention (Month 9 or Month 18)

  • Change in Number of Participants with Viral Suppression

    HIV-1 viral load is measured in viral copies per milliliter (mL) of blood and viral suppression is defined as \<200 copies/ml.

    Baseline, After the 9 month intervention (Month 9 or Month 18)

Secondary Outcomes (10)

  • Acceptability of Intervention Measure (AIM) Score

    Baseline, After the 9 month intervention (Month 9 or Month 18)

  • Intervention Appropriateness Measure (IAM) Score

    Baseline, After the 9 month intervention (Month 9 or Month 18)

  • Feasibility of Intervention Measure (FIM) Score

    Baseline, After the 9 month intervention (Month 9 or Month 18)

  • HIV Adolescent Readiness for Transition Scale (HARTS) Score

    Baseline, Month 9, Month 18, Month 24

  • Participation Rate

    Baseline, After the 9 month intervention (Month 9 or Month 18)

  • +5 more secondary outcomes

Other Outcomes (5)

  • Child and Adolescent Social Support Scale (CASSS) Score

    Baseline, After the 9 month intervention (Month 9 or Month 18)

  • Rosenberg's Self-Esteem Scale Score

    Baseline, After the 9 month intervention (Month 9 or Month 18)

  • Patient Health Questionnaire (PHQ-9) Score

    Baseline, After the 9 month intervention (Month 9 or Month 18)

  • +2 more other outcomes

Study Arms (5)

In-person adolescent-friendly service (iPAS) intervention:

EXPERIMENTAL

Adolescents at study clinics who score low or intermediate on transition readiness during screening will be invited to enroll in the study. Adolescents attending clinics randomized to the in-person supported adolescent friendly services will attend their clinic after school hours on a designated day or on weekends dedicated for adolescent care monthly for 9 months.

Behavioral: In-person adolescent-friendly service (iPAS) intervention

mHealth (InTSHA) intervention

EXPERIMENTAL

Adolescents at study clinics who score low or intermediate on transition readiness during screening will be invited to enroll in the study. Adolescents attending clinics randomized to the mHealth intervention will receive the InTSHA intervention based in the Got Transition elements and the SMART model for 9 months.

Behavioral: mHealth (InTSHA) intervention

Standard of Care/Delayed Intervention

ACTIVE COMPARATOR

Adolescents at study clinics who score low or intermediate on transition readiness during screening will be invited to enroll in the study. Adolescents attending clinics randomized to deliver the standard of care before transitioning to adult care in their standard local adult clinic. Participants will be invited to receive the intervention the clinic is randomized to deliver when the 9 month period of administering the standard of care is complete.

Behavioral: Standard of Care

Healthcare Providers

NO INTERVENTION

Healthcare providers working at one of study clinics, administering the study intervention selected for that clinic.

Observational cohort

NO INTERVENTION

Adolescents at study clinics who score high on transition readiness during screening will not be invited to enroll in the study but will be asked for their consent to have their clinic records reviewed for medical records, retention data and transition readiness data. They will also complete a questionnaire at Months 9, 18, and 24.

Interventions

Monthly visits take place in a group setting with sessions led by peer educators. Clinical staff and peer educators are trained in care of adolescents using the Right to Care training materials. During their clinic visit, adolescents are evaluated individually by a healthcare provider and receive their supply of ART. In addition, adolescents participate in scheduled group team-building activities including dancing, sports, music and receive group counseling facilitated by peer educators. Nine group counseling sessions will discuss the topics of: HIV disclosure, alcohol and substance abuse, HIV knowledge, ART adherence and HIV resistance, goal setting and career planning, sexual and reproductive health, HIV stigma, healthcare navigation and self-advocacy, and healthy relationships. The half-day sessions will end with the provision of a meal. After completion of the 9-month intervention, adolescents will transition to adult care in their standard local adult clinic.

In-person adolescent-friendly service (iPAS) intervention:

The InTSHA intervention is based on Got Transition elements (two-way messaging between adolescents and healthcare providers) and the SMART model. The SMART model focuses on modifiable factors of transition preparation through content delivery, facilitated discussions, online meet ups and consultation with the healthcare team. The intervention consists of 9 modules delivered monthly by group chat. The topics of the modules are: HIV disclosure, alcohol and substance abuse, HIV knowledge, ART adherence and HIV resistance, goal setting and career planning, sexual and reproductive health, HIV stigma, healthcare navigation and self-advocacy, and healthy relationships. Outside of scheduled group chat sessions, adolescents have access to the chat group to check in with members, review content of the sessions, or to comment or ask additional questions. After completion of the 9-month intervention, adolescents will transition to adult care in their standard local adult clinic.

mHealth (InTSHA) intervention

Adolescents in standard of care are seen every three months by clinicians and collect medication monthly at an on-site pharmacy during regular weekdays. Individual counseling delivered by counselors or social workers is available when necessary. Staff at all clinics receive training in adolescent-friendly services (AFS) through the Right to Care training materials.

Standard of Care/Delayed Intervention

Eligibility Criteria

Age15 Years - 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Aged 15 to 19 years at enrollment
  • Living with perinatally-acquired HIV
  • Receiving ART for at least 6 months
  • Aware of their HIV status
  • Scoring low to intermediate on transition readiness assessment (intervention cohort only)
  • Profession as a healthcare provider
  • Working at one of the designated clinics
  • Involvement with adolescents before, during or after transition to adult care

You may not qualify if:

  • Inability to read and/or speak English or Zulu
  • Severe mental or physical illness preventing participation in informed consent activities
  • Anticipated move out of clinic area in the next 12 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

King Edward VIII Hospital

KwaKhangela, South Africa

Location

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Interventions

MethodsTelemedicineStandard of Care

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Intervention Hierarchy (Ancestors)

Investigative TechniquesDelivery of Health CarePatient Care ManagementHealth Services AdministrationQuality Indicators, Health CareQuality of Health CareHealth Care Quality, Access, and Evaluation

Study Officials

  • Brian C Zanoni, MD, MPH

    Emory University

    PRINCIPAL INVESTIGATOR
  • Mohendran Archary, MBchB

    King Edward VIII Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This study uses a stepped-wedge, delayed implementation randomized clinical trial design, to measure the effectiveness of the interventions compared to standard of care.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 6, 2023

First Posted

September 13, 2023

Study Start

February 2, 2024

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

March 9, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

De-identified, individual participant data will be made available for sharing, including demographic information, clinic information, and study and survey data.

Shared Documents
STUDY PROTOCOL
Time Frame
Data will be made available for sharing following publication of results from this study.
Access Criteria
Data will be made available for sharing through the Emory Dataverse. The Dataverse website can be accessed by any researcher for secondary analyses.

Locations